PTC Therapeutics Inc.
PTCT | NASDAQ
$65.26
-$0.11 (-0.17%)
At close: Sep 21, 2026, 4:00 PM ET
$73.01
+$7.75 (+11.88%)
Pre-market:
Sep 22, 2026, 8:45 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 8.85 | -9.54 | -3.29 | -4.90 | -5.36 | -9.19 |
PEG Ratio | -0.03 | 0.22 | -0.44 | -1.01 | -0.45 | -0.17 |
PS Ratio | 3.49 | 4.30 | 2.20 | 3.92 | 5.21 | 10.58 |
PB Ratio | -29.43 | -3.16 | -2.52 | -7.89 | 1.95K | 8.36 |
P/FCF Ratio | 8.60 | -19.07 | -7.39 | -5.38 | -8.34 | -16.12 |
P/OCF Ratio | 8.49 | -32.21 | -13.02 | -7.68 | -11.17 | -20.76 |
OCF/S Ratio | 41.09 | -13.35 | -16.89 | -51.04 | -46.66 | -50.97 |
Debt / Equity Ratio | -2.40 | -2.25 | -2.72 | -4.21 | 882.73 | 0.87 |
Quick Ratio | 2.27 | 2.31 | 1.97 | 1.65 | 1.84 | 4.37 |
Current Ratio | 2.35 | 2.35 | 2.02 | 1.71 | 1.87 | 4.44 |
Asset Turnover | 0.59 | 0.47 | 0.49 | 0.41 | 0.28 | 0.17 |
Interest Coverage | 5.63 | -1.81 | -3.40 | -4.92 | -4.35 | -7.66 |
Return on Equity | -332.49% | 33.08% | 76.55% | 161.06% | -36.43K% | -90.91% |
Return on Assets | 23.45% | -21.31% | -33.05% | -32.77% | -27.03% | -19.84% |
Return on Invested Capital | 37.39% | -21.69% | -26.32% | -30.76% | -22.72% | -22.26% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 95.85% | 92.89% | 93.02% | 93.61% | 94% | 95.03% |
Net Profit Margin | 39.44% | -45.03% | -66.81% | -80% | -97.27% | -115.07% |
Pretax Profit Margin | 40.25% | -45.01% | -74.23% | -84.07% | -96.24% | -105.82% |
Operating Profit Margin | 49.49% | -37.50% | -46.86% | -64.03% | -69.52% | -113.39% |
FCF Margin | 40.58% | -22.55% | -29.75% | -72.86% | -62.51% | -65.67% |
EBITDA Margin | 51.29% | -14.93% | -35.22% | -52.63% | -68.36% | -79.60% |
Add to Watchlist
Select watchlists to add or remove PTCT